Connected Diagnostics: Neopharma Technologies and Digital Workflows

Connected diagnostics bring test collection, results, review and reporting into one traceable workflow. For HR, safety and occupational health teams, this reduces disconnected records and improves oversight of workplace drug, alcohol and impairment screening. Neopharma Technologies Limited develops NEOVAULT to connect point-of-care testing with digital chain of custody, review and multi-site reporting. This article explains how connected workplace testing works, which NEOVAULT features support it and what employers should assess before using digital diagnostic workflows across locations and testing providers.

What Are Connected Diagnostics and Why Do Digital Workflows Matter?

Connected diagnostics bring testing information into a traceable process instead of leaving results in separate devices, forms and spreadsheets. In workplace programmes, digital diagnostic workflows connect collection details with review, follow-up and reporting. This improves access to relevant records while keeping clinical diagnosis distinct from operational screening.

From Standalone Test Results to Connected Data

A standalone result may lack collection details and follow-up history. Connected records preserve that context. For example, a photograph sent by email might omit the collector, location or review status. Structured records let a manager check these details without asking staff to reconstruct the event after a shift. The WHO digital health strategy (2020-2027) calls for digital health initiatives to integrate organisational, human and technological resources.

Why Workplace Testing Needs a Connected Workflow

Safety managers oversee multiple shifts, testing providers and sites. Connected records make three tasks easier:

• Spot gaps: Find incomplete collection details or outstanding reviews.
• Coordinate follow-up: Track confirmation or escalation under workplace policy.
• Maintain accountability: Separate screening information from employment decisions.

How Is Neopharma Technologies Advancing Connected Diagnostics?

Neopharma Technologies Limited is an Australian digital health technology company developing NEOVAULT for workplace drug, alcohol and impairment screening. Its focus is to connect point-of-care collection with digital records, management visibility and fit-for-duty workflows. The company does not position NEOVAULT as a general-purpose laboratory diagnostic system.

Neopharma Technologies' Approach to Digital Workplace Testing

Neopharma connects test capture with chain of custody and reporting. The Neopharma Technologies company profile explains its workplace focus. Employers gain consistent records across collectors and sites, while designated reviewers can follow testing events through documented outcomes.

How NEOVAULT Fits Into Neopharma's Technology Strategy

NEOVAULT connects field activity with management review through related digital workflows:

• Testing: Record workplace drug and alcohol screening.
• Impairment: Include screening results in fit-for-duty review.
• Oversight: Give authorised teams access to relevant records.

Site policy and trained reviewers remain responsible for decisions.

How Do Connected Diagnostic Workflows Operate from Testing to Reporting?

Connected diagnostic workflows follow a defined sequence: initiate the test, capture identifiers and results, preserve the handling record, review any exceptions and report the outcome to authorised users. Each handover needs enough detail to make the record understandable later. Electronic workflows can reduce duplicate transcription, but human oversight remains essential.

Digital Test Initiation and Point-of-Care Data Capture

Collectors use approved procedures to capture the information needed for later review:

• Identity: Match the worker with the testing event.
• Kit details: Scan the QR code or barcode.
• Outcome: Record results and supporting collection details.

Digital Chain of Custody and Result Review

A digital chain of custody records handling and timestamps for later review:

• Traceability: Identify handlers, handovers and recorded actions.
• Follow-up: Distinguish screening from required confirmation.

The CLSI point-of-care testing guidance covers specimen-based testing outside laboratories, including nonclinical settings. It excludes breath analysers and does not certify NEOVAULT or govern workplace employment decisions.

Real-Time Reporting and Multi-Site Visibility

Authorised managers can review records across locations through a shared reporting view:

• Exceptions: Find incomplete or unresolved records.
• Coverage: Compare testing activity between sites.
• Context: Keep different test types distinct in reports.

Illustrative workflow; dashboard figures are not real results

Which NEOVAULT Features Support Connected Diagnostics?

NEOVAULT combines mobile collection, drug and alcohol testing, impairment risk management and reporting in one workplace platform. These functions connect field activity with oversight, which can be useful where multiple teams share responsibility for testing. Each component addresses a particular handover in the process rather than replacing organisational judgement.

• myNEO Mobile App: Guided digital forms and QR or barcode scanning support field collection. Offline capture allows later synchronisation; teams still need procedures for verifying records and handling delayed uploads.
• Drug & Alcohol Testing: The module organises scheduled, random, pre-employment and post-incident programmes. Results and digital chain-of-custody records stay connected, helping reviewers trace events under their organisation's testing procedures.
• Impairment Risk Management (IRM): Integration with DRUID adds cognitive and psychomotor screening to fit-for-duty workflows. Neopharma's workplace drug, alcohol and impairment testing technology connects relevant records; screening informs review rather than medical diagnosis.
• Reporting & Analytics: Dashboards, site-level views and exports help authorised managers track activity and outstanding records. Teams can assess whether available reports meet their internal review and audit requirements.

A NEOVAULT walkthrough can help teams see how these modules connect within their own testing programme.

What Should Global Organisations Consider Before Connecting Diagnostic Workflows?

A global rollout needs consistent core processes alongside rules that reflect each operating location. Privacy, authorised access, testing methods and record retention may vary by jurisdiction and contract. Technology can support those requirements, but employers must confirm their own obligations before applying one policy to every workforce.

Data Privacy, Access Controls and Auditability

Workplace testing records are sensitive. Before rollout, define access, retention and review responsibilities:

• Access: Limit results to authorised roles and review third-party permissions.
• Audit history: Record changes, responsible users and earlier versions.
• Retention: Confirm correction, export and deletion procedures for each location.

Regional Testing Requirements and Organisational Policies

Testing requirements vary by country and industry. Local teams should document:

• Methods: Approved tests and any required confirmation.
• Decisions: Escalation routes and authorised reviewers.

The ILO occupational safety management guidance supports risk controls within established management systems, not a substitute for local law.

Scaling Across Sites Without Losing Workflow Consistency

Pilot the workflow at one site before expanding across locations. Check:

• Consistency: Shared fields and approval steps.
• Local needs: Site-specific procedures and permissions.
• Connectivity: Offline records and delayed synchronisation.

How Can Organisations Evaluate a Connected Diagnostics Platform?

Evaluate connected diagnostics against real operating problems, not a list of software functions. Map where records are lost, reviews stall or site reports disagree. Then test whether a platform supports collection, traceability, access controls and reporting within your policies, staffing arrangements and existing systems.

• Data entry: Trace a recent test from collection to closure and identify fields entered repeatedly across systems.
• Handover ownership: Check who receives results, handles exceptions and closes unresolved cases.
• Record retrieval: Measure how quickly reviewers can find a complete testing history, including chain-of-custody details.
• Access and integration: Test role permissions, offline synchronisation, retention rules, API needs and export formats.
• Rollout readiness: Demonstrate workflows using real roles and sample records, then confirm responsibilities across sites.

The NEOVAULT connected workplace testing platform provides a practical starting point for reviewing these requirements.

Frequently Asked Questions About Connected Diagnostics

Workplace leaders usually want to know whether connected testing changes the tests themselves, who can see the information and how screening informs decisions. The short answers below distinguish software capabilities from clinical judgement and employer obligations. They also clarify how NEOVAULT supports field teams and organisations operating across several locations.

What is connected diagnostics in workplace testing?

Connected diagnostics means linking a workplace test to its collection details, chain of custody, review status and reporting record. The result remains subject to the relevant testing procedure. The connection helps authorised teams find information and understand what happened without rebuilding the record manually.

How does NEOVAULT connect testing results with digital workflows?

NEOVAULT uses mobile collection and a central platform to connect drug, alcohol and impairment screening activity with records and reporting. The myNEO app supports field capture, while modules organise testing and oversight. Actual configurations should be checked against the organisation's operating requirements.

Can connected diagnostics support fitness-for-duty decisions?

Yes, connected records can give reviewers relevant screening information and a clearer history of the event. NEOVAULT's IRM module adds cognitive and psychomotor screening through DRUID. Employers still need an appropriate policy, competent review and any required confirmatory procedures before making decisions.

Can NEOVAULT support testing across multiple workplace locations?

Yes. NEOVAULT provides central reporting and visibility across sites, helping managers review activity without gathering separate spreadsheets. Organisations should confirm site permissions, local procedures, connectivity and retention settings during implementation. A multi-site dashboard does not remove the need for accountable people at each location.

Connected diagnostics help employers keep workplace testing records complete and traceable from collection through review and reporting. Digital workflows make it easier to identify outstanding actions, share information with authorised teams and compare activity across sites. Effective programmes still depend on appropriate testing procedures, clear access rules and people accountable for decisions. NEOVAULT supports these needs through mobile collection, digital chain of custody, impairment screening and reporting. Teams can review those functions against their workplace processes during a product walkthrough.